Literature DB >> 17494723

emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years?

Roberta Creti1, Monica Imperi, Lucilla Baldassarri, Marco Pataracchia, Simona Recchia, Giovanna Alfarone, Graziella Orefici.   

Abstract

To investigate the epidemiology and characteristics of invasive group A streptococcal (GAS) disease over 11 years in Italy, this study compared the emm types and the superantigen toxin genes speA and speC as well as the erythromycin, clindamycin, and tetracycline susceptibilities of 207 invasive GAS strains collected during two national enhanced surveillance periods (1994 to 1996 and 2003 to 2005) and the time between each set of surveillance periods. The present study demonstrated that emm1 strains were consistently responsible for about 20% of invasive GAS infections, while variations in the frequencies of the other types were noted, although the causes of most cases of invasive infections were restricted to emm1, emm3, emm4, emm6, emm12, and emm18. During the 1994 to 1996 surveillance period, an emm89 epidemic clone spread across the northern part of Italy. A restricted macrolide resistance phenotype-type distribution of the bacteriophage-encoded speA toxin as well as of macrolide resistance genes was noted over time. Indeed, the recent acquisition of macrolide resistance in previously susceptible emm types was observed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17494723      PMCID: PMC1933002          DOI: 10.1128/JCM.00513-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates.

Authors:  Franz-Josef Schmitz; Andreas Beyer; Emmanuelle Charpentier; Birgitta Henriques Normark; Marc Schade; Ad C Fluit; Dieter Hafner; Rodger Novak
Journal:  J Infect Dis       Date:  2003-11-05       Impact factor: 5.226

2.  Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel.

Authors:  Ran Nir-Paz; Colin Block; David Shasha; Zinaida Korenman; Zeev Gorodnitzky; Joseph Jaffe; Merav Ron; Ayelet Michael-Gayego; Ronit Cohen-Poradosu; Mervyn Shapiro; Allon E Moses
Journal:  Int J Antimicrob Agents       Date:  2006-09-14       Impact factor: 5.283

3.  Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes.

Authors:  Ramy K Aziz; Robert A Edwards; William W Taylor; Donald E Low; Allison McGeer; Malak Kotb
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

4.  Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive disease.

Authors:  David J McMillan; R G Beiko; R Geffers; Jan Buer; L M Schouls; B J M Vlaminckx; W J B Wannet; K S Sriprakash; G S Chhatwal
Journal:  Clin Infect Dis       Date:  2006-08-23       Impact factor: 9.079

5.  Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study.

Authors:  Kim Ekelund; Peter Skinhøj; Jesper Madsen; Helle Bossen Konradsen
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 6.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

Review 7.  Uncovering the mysteries of invasive streptococcal diseases.

Authors:  Gursharan S Chhatwal; David J McMillan
Journal:  Trends Mol Med       Date:  2005-04       Impact factor: 11.951

8.  emm typing of invasive T28 group A streptococci, 1995-2004, Finland.

Authors:  Tuula Siljander; Maija Toropainen; Anna Muotiala; Nancy P Hoe; James M Musser; Jaana Vuopio-Varkila
Journal:  J Med Microbiol       Date:  2006-12       Impact factor: 2.472

9.  Characterisation of group A streptococcal (GAS) isolates from children with tic disorders.

Authors:  R Creti; F Cardona; M Pataracchia; C Von Hunolstein; G Cundari; A Romano; G Orefici
Journal:  Indian J Med Res       Date:  2004-05       Impact factor: 2.375

10.  Detection of Tet M and Tet O tetracycline resistance genes by polymerase chain reaction.

Authors:  M C Roberts; Y Pang; D E Riley; S L Hillier; R C Berger; J N Krieger
Journal:  Mol Cell Probes       Date:  1993-10       Impact factor: 2.365

View more
  17 in total

1.  Description of macrolide-resistant and potential virulent clones of Streptococcus pyogenes causing asymptomatic colonization during 2000-2006 in the Lisbon area.

Authors:  R Pires; D Rolo; A Morais; A Brito-Avô; C Johansson; B Henriques-Normark; J Gonçalo-Marques; I Santos-Sanches
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-21       Impact factor: 3.267

Review 2.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

3.  Sequence type and emm type diversity in Streptococcus pyogenes isolates causing invasive disease in Norway between 1988 and 2003.

Authors:  Roger Meisal; E Arne Høiby; Ingeborg S Aaberge; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2008-04-16       Impact factor: 5.948

4.  Epidemiology of severe Streptococcus pyogenes disease in Europe.

Authors:  Theresa L Lamagni; Jessica Darenberg; Bogdan Luca-Harari; Tuula Siljander; Androulla Efstratiou; Birgitta Henriques-Normark; Jaana Vuopio-Varkila; Anne Bouvet; Roberta Creti; Kim Ekelund; Maria Koliou; Ralf René Reinert; Angeliki Stathi; Lenka Strakova; Vasilica Ungureanu; Claes Schalén; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

5.  Epidemiology of Invasive Group A Streptococcal Disease in Alaska, 2001 to 2013.

Authors:  Karen Rudolph; Michael G Bruce; Dana Bruden; Tammy Zulz; Alisa Reasonover; Debby Hurlburt; Thomas Hennessy
Journal:  J Clin Microbiol       Date:  2015-11-11       Impact factor: 5.948

6.  Long-term, single-center surveillance of non-invasive group A streptococcal (GAS) infections, emm types and emm clusters.

Authors:  Peter Konrad; Markus Hufnagel; Reinhard Berner; Nicole Toepfner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-22       Impact factor: 3.267

7.  Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe.

Authors:  Bogdan Luca-Harari; Jessica Darenberg; Shona Neal; Tuula Siljander; Lenka Strakova; Asha Tanna; Roberta Creti; Kim Ekelund; Maria Koliou; Panayotis T Tassios; Mark van der Linden; Monica Straut; Jaana Vuopio-Varkila; Anne Bouvet; Androulla Efstratiou; Claes Schalén; Birgitta Henriques-Normark; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

8.  An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes.

Authors:  S Steve Yan; Paul C Schreckenberger; Xiaotian Zheng; Nancy A Nelson; Susan M Harrington; Joyce Tjhio; Daniel P Fedorko
Journal:  Diagn Microbiol Infect Dis       Date:  2008-06-12       Impact factor: 2.803

9.  Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010.

Authors:  Patrick R Shea; Amy L Ewbank; Javier H Gonzalez-Lugo; Alexandro J Martagon-Rosado; Juan C Martinez-Gutierrez; Hina A Rehman; Monica Serrano-Gonzalez; Nahuel Fittipaldi; Stephen B Beres; Anthony R Flores; Donald E Low; Barbara M Willey; James M Musser
Journal:  Emerg Infect Dis       Date:  2011-11       Impact factor: 6.883

10.  Invasive Streptococcus pyogenes disease in Spain: a microbiological and epidemiological study covering the period 2007-2019.

Authors:  Pilar Villalón; Juan A Sáez-Nieto; Virginia Rubio-López; María José Medina-Pascual; Noelia Garrido; Gema Carrasco; Silvia Pino-Rosa; Sylvia Valdezate
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-05-27       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.